National Health Investors, Inc. (NYSE:NHI – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $76.33.
Several research firms have recently weighed in on NHI. Bank of America initiated coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target on the stock. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Truist Financial upped their price target on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research report on Friday, August 30th. Finally, Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price objective for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st.
Get Our Latest Analysis on NHI
Hedge Funds Weigh In On National Health Investors
National Health Investors Trading Down 0.1 %
National Health Investors stock opened at $68.84 on Friday. National Health Investors has a one year low of $51.59 and a one year high of $86.13. The business’s fifty day moving average is $76.18 and its 200 day moving average is $75.52. The stock has a market capitalization of $3.13 billion, a PE ratio of 23.66, a price-to-earnings-growth ratio of 4.86 and a beta of 1.04. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29.
National Health Investors (NYSE:NHI – Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The company had revenue of $63.32 million for the quarter, compared to analysts’ expectations of $67.93 million. During the same period in the previous year, the business earned $1.08 EPS. The business’s revenue was up 1.7% compared to the same quarter last year. On average, sell-side analysts predict that National Health Investors will post 4.42 EPS for the current year.
National Health Investors Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.23%. National Health Investors’s dividend payout ratio (DPR) is presently 123.71%.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Micron Stock Under $100: Seize the AI-Driven Upside
- Insider Trades May Not Tell You What You Think
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What to Know About Investing in Penny Stocks
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.